Facts About Vein Disease

Below are some facts about vein disease and the ClosureFast™ procedure:

• More than 190 million people have CVI or varicose veins globally.
• More than 30 million Americans suffer from varicose veins, or the more serious form of venous disease called chronic venous insufficiency (CVI), yet the majority remain undiagnosed and untreated.
• If left untreated, varicose veins can progress to CVI5, which can cause pain, swelling and fatigue of the legs, as well as skin damage and ulcers, in more severe cases.
• It is time for individuals to think differently about varicose veins and their complications and understand that they may not just be a cosmetic issue, but a health concern worthy of medical diagnosis and treatment.
• Many people misunderstand the causes, risks and treatments for varicose veins.
• With varicose veins and CVI, the valves that push blood from the legs back to the heart no longer function, causing blood to pool in the legs.
• There are a number of factors that contribute to these conditions, including pregnancy, prolonged sitting or standing, excess weight, lack of exercise, age (50+) and family history.
• Women are two times more likely than men to develop varicose veins, primarily due to pregnancy.
• Many people are unaware of the ClosureFast™ procedure; the only FDA cleared minimally invasive treatment that uses radiofrequency ablation (uniform heat) for the treatment of CVI to seal off the problem vein, so blood gets re-routed to healthy veins.
• Covered by most insurance plans (patients should contact their insurance provider prior to receiving treatment to confirm that the ClosureFast™ procedure is covered), the ClosureFast™ procedure allows for a short, comfortable recovery and a quick return to everyday activities while also eliminating varicose veins and improving the appearance of the legs.
• Studies show that the ClosureFast™ procedure is associated with lower rates of pain, bruising and complications when compared to 980 nm laser.
• Data published in the British Journal of Surgery found that CVI patients treated with the ClosureFast™ procedure demonstrated high closure rates and reduction in patient pain scores at five years.
• The ClosureFast™ procedure allows for a short, comfortable recovery and a quick return to everyday activities.
• Medtronic ClosureFastTM catheters are backed by five years of clinical data and are sold as a single-use device designed to be used only one time, on one patient.
• Individual results may vary. As with all medical procedures, there is a chance that complications may occur, including, but not limited to the following: hematoma, vessel perforation, thrombosis, pulmonary embolism, phlebitis, infection, adjacent nerve injury, skin burn or discoloration.